Phenibut-Astrapharm 20 tabs (250 mg/1 tab)

Psychological indicators (attention, memory, speed and accuracy of sensory-motor reactions) under the influence of phenibut are improved, in contrast to the action of tranquilizers. The drug lengthens the latency period and reduces the duration and severity of nystagmus, has an antiepileptic effect. Does not affect choline and adrenergic receptors.

Phenibut-Astrafarm significantly reduces the manifestations of asthenia and vaso-vegetative symptoms, including headache, a feeling of heaviness in the head. In patients with asthenia and in emotionally labile persons, from the very first days of therapy with Phenibut, well-being improves, interest and initiative, motivation of activity without unwanted sedation or excitement increase. It has been found that Phenibut improves brain bioenergetics.

Indications for taking Phenibut a

Asthenic and anxious-neurotic states (emotional lability, memory impairment, decreased concentration), anxiety, fear, anxiety, obsessive-compulsive disorder. Children over 8 years old have stuttering, enuresis, tics. Elderly patients have insomnia, nighttime restlessness.

Prevention of stressful conditions, before surgery or painful diagnostic tests. Meniere's disease, dizziness associated with dysfunction of the vestibular apparatus, prevention of motion sickness. As an aid during the treatment of withdrawal symptoms in alcoholism. More details:

Contraindications

Hypersensitivity to the components of the drug. About Stra renal failure.

Interaction with other medicinal products

Phenibut can be combined with psychotropic drugs, reducing the dose of the drug and the drugs used with it. Phenibut enhances and lengthens the effect of hypnotics, narcotic, neuroleptic and antiparkinsonian drugs.

Features of the use of Phenibut a

Caution should be exercised in patients with digestive tract pathology and due to the irritating effect of phenibut. These patients should be given lower doses. With prolonged use, it is necessary to control the cellular composition of the blood, indicators of liver function.

The drug contains lactose, therefore, patients with rare hereditary forms of galactose intolerance, lactase deficiency or glucose-galactose malabsorption syndrome should not use this drug.

Method of administration and dosage

Phenibut-Astrafarm is taken orally before meals. For asthenic and anxiety-neurotic states, adults are prescribed 250-500 mg 3 times a day. The highest single dose for adults is 750 mg, for elderly patients - 500 mg.

The course of treatment is 2-3 weeks. If necessary, the course of treatment can be increased to 4-6 weeks.

Children over 8 years old - 250 mg 3 times a day, children over 14 years old - doses for adults.

With dizziness associated with dysfunction of the vestibular apparatus of infectious genesis and with Meniere's disease, the drug is prescribed 750 mg 3 times a day for 5-7 days, with a decrease in the severity of vestibular disorders - 250-500 mg 3 times a day for 5-7 days, and then 250 mg 1 time per day for 5 days.

With a relatively mild course of diseases, Phenibut-Astrafarm is used at 250 mg 2 times a day for 5-7 days, and then 250 mg once a day for 7-10 days.

In case of dizziness associated with dysfunction of the vestibular apparatus of the vascular and traumatic genesis, Phenibut-Astrafarm is prescribed 250 mg 3 times a day for 12 days.

For the prevention of motion sickness, a dose of 250-500 mg is prescribed once 1 hour before the scheduled start of rolling when the first symptoms of motion sickness appear. The effect of phenibut is enhanced with an increase in the dose of the drug.

In the presence of severe manifestations (vomiting and nausea), the use of the drug is ineffective even at a dose of 750-1000 mg.